TNBC is a notorious subtype of breast cancer lacking estrogen receptor, progesterone receptor, and human epidermal growth factor receptor‐2 overexpression, accounting for 10%–24% of all breast cancers [2]. This evidence concerns the gene ESR1 and breast carcinoma.